| Title | Date | PubMed ID |
|---|
| Progress in metallocarboxypeptidases and their small molecular weight inhibitors. | 2010 Nov | 20466032 |
| Measurement of carboxypeptidase U (active thrombin-activatable fibrinolysis inhibitor) in plasma: Challenges overcome by a novel selective assay. | 2010 Aug | 20371219 |
| Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma. | 2010 Jan 1 | 19732738 |
| The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome. | 2010 Jan | 19874466 |
| Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? | 2009 Dec | 19719827 |
| Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia. | 2009 Sep | 19195685 |
| EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats. | 2009 May | 19325462 |
| Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease. | 2009 Apr | 19298343 |
| Functional analysis of mutant variants of thrombin-activatable fibrinolysis inhibitor resistant to activation by thrombin or plasmin. | 2009 Apr | 19335449 |
| The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme? | 2009 Mar | 19054324 |